Sign in

CIK 0000874716

  • Large accelerated filer

IDEXX LABORATORIES INC /DE

Sign in to watch
Ticker
IDXX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
010393723
Phone
+1 207-556-0300
Business address
ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
  1. 4 Open-market sale EVP, GC & Corporate Secretary sold 5,450 shares at $651.60 ($3,551,220)
  2. 4 Exercise or conversion President and CEO acquired 183 shares (option exercise)
  3. 4 Exercise or conversion EVP, CFO and Treasurer acquired 1,849 shares (option exercise)
  4. 4 Open-market sale Executive Vice President sold 7,143 shares at an average $630.43 ($4,503,163)
  5. 4 Open-market sale President and CEO sold 29,260 shares at an average $631.98 ($18,491,642)
  6. 4 Open-market sale Executive Vice President sold 8,411 shares at an average $627.74 ($5,279,893)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Shares withheld for taxes Executive Vice President gave up 1,499 shares (to pay taxes)
  9. 4 Open-market sale Director sold 2,306 shares at an average $512.97 ($1,182,917)
  10. 4 Open-market sale Director sold 2,683 shares at $506.41 ($1,358,697)
  11. 4 Open-market sale Director sold 1,279 shares at $491.34 ($628,425)
  12. 4 Exercise or conversion Director acquired 262 shares (option exercise)
  13. 4 Exercise or conversion Director acquired 262 shares (option exercise)
  14. 4 Derivatives Options or other derivatives
  15. 4 Exercise or conversion Director acquired 346 shares (option exercise)
  16. 4 Exercise or conversion Director acquired 262 shares (option exercise)
  17. 4 Exercise or conversion Director acquired 262 shares (option exercise)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 4 of 74 · 1,467 filings